A: It should be kept out of reach of children, stored in a cool and dry place away from sunlight and used only under medical supervision for best results
"GLP-1 receptor agonist use was associated with a higher risk of clinically recorded alopecia, particularly non-scarring alopecia, in patients with type 2 diabetes, compared with SGLT-2 and DPP-4 inhibitors," write the researchers in their published paper
This review offers a contemporary analysis of the current state of understanding HU, its underlying causes, associated health risks, diagnostic approaches, treatment strategies, and prospects for future research and management
We review your lab work every 3 months to ensure that the treatment is both safe and effective, making any necessary modifications to optimize your results
For this reason, semaglutide isnt advised for people with a personal or family history of Multiple Endocrine Neoplasia syndrome type 2B, which is a rare disorder of the endocrine system
